Nexus AI CXR is a CE MDR Class IIb certified medical device that analyses chest X-rays and indicates findings not consistent with a normal lung field, including patterns suggestive of pulmonary tuberculosis. It supports and does not replace clinical interpretation and diagnosis.
Published in The Lancet. Powered by Google. Trusted by clients.
An integrated enterprise AI platform supporting population screening, radiology workflows, and occupational lung health programmes – developed for flexible deployment across diverse clinical environments.
Nexus is a connected platform that brings together our CE-certified medical device for chest X-ray screenings, multi-pathology, and LLM capabilities, integrated within a broader lung health ecosystem – optimising workflows and delivering faster, more coordinated screening outcomes.
A CE-certified medical device that analyses chest X-rays and indicates findings not consistent with a normal lung field, including patterns suggestive of pulmonary tuberculosis. The algorithm comprises two core models – Normal and TB – that run in parallel on every chest X-ray.
Builds on the CE-certified Nexus AI CXR and adds an extra layer of classification – assigning descriptive labels to certain radiological findings, plus LLM-assisted clinical insights and structured reporting. Internally validated. We are currently in the process to expand our CE certification.
Nexus AI CXR is integrated with Healthcare Framework (clinical management) and CloudX (central radiology reporting) to deliver coordinated screening – from a single chest X-ray to a complete patient pathway. Holistic approach for optimal outcomes.
Nexus AI CXR was developed on over 460,000 chest X-rays from 10 countries across diverse populations and imaging modalities, and has been independently validated by both Nexus and Google. Both the Normal model and the TB model met or exceeded the World Health Organization's performance thresholds (≥90% sensitivity, ≥70% specificity).
Nexus AI CXR was further independently validated by the Stop TB Partnership and ranked as one of the top two performing models as published in The Lancet – confirmed across HIV-positive, female, male, and age subgroups.
Nexus continues to refine our models through ongoing post-market surveillance and additional training – a commitment to continuous improvement in real-world clinical performance.
Read the publication →From mobile screening clinics in rural Africa to deep-shaft mining sites in South Africa, Nexus AI is supporting lung health across diverse healthcare environments.
Book a 30-minute platform walkthrough with our clinical team. We'll show you live AI analysis, integration options, and walk you through deployment in your environment.